Skip to search formSkip to main contentSkip to account menu

Refractory Childhood Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia that occurs in childhood and does not respond to treatment.
National Institutes of Health

Related topics

Related topics

13 relations
Atypical lymphocyteBone MarrowHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
When to Refer a Patient for CAR T-Cell Therapy
2018
2018
Identification of direct targets of the oncogenic fusion protein TCF3-HLF in treatment refractory childhood acute lymphoblastic leukemia
2014
2014
Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia.
Clofarabine, one of the key treatment agents for refractory and relapsed acute lymphoblastic leukemia (ALL), achieves a remission… 
2010
2010
A phase I study of clofarabine and liposomal daunorubicin in childhood and adolescent acute myeloid leukemia.
TPS327 Background: This phase I study evaluates the tolerability of clofarabine with liposomal daunorubicin in patients with… 
2009
2009
Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia
Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia 
2008
2008
Early relapse after rituximab chemoimmunotherapy
In relapsed/refractory childhood acute lymphoblastic leukemia (ALL) of the B‐cell lineage rituximab, a monoclonal anti‐CD20… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)